Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model

被引:0
|
作者
Janin Henkel
Charles Dominic Coleman
Anne Schraplau
Korinna Jöhrens
Thomas Siegfried Weiss
Wenke Jonas
Annette Schürmann
Gerhard Paul Püschel
机构
[1] University of Potsdam,
[2] Institute of Nutritional Science,undefined
[3] Department of Nutritional Biochemistry,undefined
[4] Charité University Hospital Berlin,undefined
[5] Institute of Pathology,undefined
[6] University Hospital Regensburg,undefined
[7] University Children Hospital (KUNO) Regensburg,undefined
[8] German Institute of Human Nutrition,undefined
[9] Department of Experimental Diabetology,undefined
[10] German Center for Diabetes Research (DZD),undefined
来源
关键词
Non-alcoholic Steatohepatitis (NASH); Microsomal Prostaglandin; Particularly Prostaglandin E2 (PGE2); NASH Livers; Diet-induced NASH;
D O I
暂无
中图分类号
学科分类号
摘要
In a subset of patients, non-alcoholic fatty liver disease (NAFLD) is complicated by cell death and inflammation resulting in non-alcoholic steatohepatitis (NASH), which may progress to fibrosis and subsequent organ failure. Apart from cytokines, prostaglandins, in particular prostaglandin E2 (PGE2), play a pivotal role during inflammatory processes. Expression of the key enzymes of PGE2 synthesis, cyclooxygenase 2 and microsomal PGE synthase 1 (mPGES-1), was increased in human NASH livers in comparison to controls and correlated with the NASH activity score. Both enzymes were also induced in NASH-diet-fed wild-type mice, resulting in an increase in hepatic PGE2 concentration that was completely abrogated in mPGES-1-deficient mice. PGE2 is known to inhibit TNF-α synthesis in macrophages. A strong infiltration of monocyte-derived macrophages was observed in NASH-diet-fed mice, which was accompanied with an increase in hepatic TNF-α expression. Due to the impaired PGE2 production, TNF-α expression increased much more in livers of mPGES-1-deficient mice or in the peritoneal macrophages of these mice. The increased levels of TNF-α resulted in an enhanced IL-1β production, primarily in hepatocytes, and augmented hepatocyte apoptosis. In conclusion, attenuation of PGE2 production by mPGES-1 ablation enhanced the TNF-α-triggered inflammatory response and hepatocyte apoptosis in diet-induced NASH.
引用
收藏
相关论文
共 50 条
  • [31] Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation
    AbdulHameed, Mohamed Diwan M.
    Hamza, Adel
    Liu, Junjun
    Huang, Xiaoqin
    Zhan, Chang-Guo
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (01) : 179 - 185
  • [32] Virtual screening, molecular simulations and bioassays: Discovering novel microsomal prostaglandin E Synthase-1 (mPGES-1) inhibitors
    Babaoglu, Zeynep Yagmur
    Kilic, Deryanur
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 155
  • [33] Microsomal prostaglandin E2 synthase-1 (mPGES-1):: A novel anti-inflammatory therapeutic target
    Friesen, Richard W.
    Mancini, Joseph A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (14) : 4059 - 4067
  • [34] Effect of Estrus Synchronization on Endometrial Prostaglandin F Synthase (PGFS) and Microsomal Prostaglandin E Synthase-1 (mPGES-1) mRNA Expression in Early Pregnant Pigs
    Blitek, A.
    Waclawik, A.
    Kaczmarek, M. M.
    Kiewisz, J.
    Ziecik, A. J.
    REPRODUCTION IN DOMESTIC ANIMALS, 2008, 43 : 90 - 90
  • [35] Expression of inducible microsomal prostaglandin E synthase 1 (mPGES-1) is regulated by mitogen-activated protein (MAP) kinase phosphatase 1
    Tuure, L.
    Hamalainen, M.
    Moilanen, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (05) : 438 - 438
  • [36] Discovery of novel microsomal prostaglandin E2 synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening study
    Olgac, Abdurrahman
    Jordan, Paul M.
    Kretzer, Christian
    Werz, Oliver
    Banoglu, Erden
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2025, 136
  • [37] Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886
    Riendeau, D
    Aspiotis, R
    Ethier, D
    Gareau, Y
    Grimm, EL
    Guay, J
    Guiral, S
    Juteau, H
    Mancini, JA
    Méthot, N
    Rubin, J
    Friesen, RW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) : 3352 - 3355
  • [38] Expression and Significance of Microsomal Prostaglandin Synthase-1 (mPGES-1) and Beclin-1 in the Development of Prostate Cancer
    Xu, Lu-Wei
    Qian, Ming
    Jia, Rui-Peng
    Xu, Zheng
    Wu, Jian-Ping
    Li, Wen-Cheng
    Huang, Wen-Bin
    Chen, Xing-Guo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1639 - 1644
  • [39] Insights on Microsomal Prostaglandin E2 Synthase 1 (mPGES-1) Inhibitors using Molecular Dynamics and MM/PBSA Calculations
    dos Santos Nascimento, Igor Jose
    de Aquino, Thiago Mendonca
    da Silva Junior, Edeildo Ferreira
    de Moura, Ricardo Olimpio
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (06) : 1033 - 1047
  • [40] Pharmacophore Modeling and Virtual Screening for Novel Acidic Inhibitors of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1)
    Waltenberger, Birgit
    Wiechmann, Katja
    Bauer, Julia
    Markt, Patrick
    Noha, Stefan M.
    Wolber, Gerhard
    Rollinger, Judith M.
    Werz, Oliver
    Schuster, Daniela
    Stuppner, Hermann
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) : 3163 - 3174